During a Case-Based Roundtable® event, John N. Allan, MD, discussed the addition of anti-CD20 antibody and the use of MRD ...

For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Despite medical advances, heart disease has remained the leading cause of death in the U.S. for more than a century, ...

Akriti Jain, MD, discussed how emerging data on non-ABL1 mutations is reshaping chronic myeloid leukemia management.

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm ...

This is a rare disease that typically affects children. It grows quickly, so people with this type will need intensive (in-depth) chemotherapy. Lymphoplasmacytic lymphoma (Waldenstrom ...

This analyzes the surface proteins on leukemia cells to confirm the diagnosis of CLL. It can also show whether the disease affects B-cell lymphocytes or T-cell lymphocytes. Knowing which type of ...